Edition:
United States

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

2.40USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$2.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,092
52-wk High
$6.64
52-wk Low
$2.30

Chart for

About

Kazia Therapeutics Limited, formerly Novogen Limited, is an oncology biotechnology company, which is focused on developing cancer treatments. The Company is primarily engaged in pharmaceutical research and development. It has two drug technology platforms (the Superbenzopyran (SBP) technology and Anti-tropomyosin (ATM)) yielding... (more)
No analyst recommendations are available for .

Overall

Beta: 1.58
Market Cap(Mil.): $17.51
Shares Outstanding(Mil.): 6.22
Dividend: --
Yield (%): --

Financials

  KZIA.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.90 -- --
ROI: -22.04 0.60 13.80
ROE: -27.09 -2.18 15.29

Earnings vs. Estimates